With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.
A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?
Dr. Mehmet Furkan Burak said people who have lost weight and then gained it again can feel guilt or shame and blame ...
Intuitively, it would seem that GLP-1 use for obesity would reduce overall medical costs despite the increase in drug ...
The National on MSN1d
Two years on, are GLP-1 drugs such as Ozempic and Mounjaro here to stay?In January 2023, the world was abuzz with stories of a revolutionary weight-loss drug – a simple, self-administered injection ...
Roche's strategic acquisition of Poseida Pharmaceuticals positions them as a leader in the allogeneic cell therapy market.
Research showed that patients who lose weight on GLP-1 agonists frequently experience muscle mass loss. Obesity experts share ...
Maridebart cafraglutide, a novel injectable GLP-1 receptor agonist/GIP receptor antagonist, reduced body weight by up to ...
News Medical on MSN4d
Do GLP-1 receptor agonists increase the risk of suicide in patients?A nationwide study confirms GLP-1 RAs pose no short-term psychiatric risk, showing a negative association with suicidal ...
This is the beginning of a revolution, and how you engage and how you attack it is going to really set the stage for your ...
Diet food brands have been hit in recent years, but now GLP-1 drugs like Ozempic are hitting the market, will this spell the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback